drugset / Trial / NCT02101905
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This pilot phase I clinical trial studies how well lapatinib ditosylate before surgery works in treating patients with high-grade glioma that has come back after a period of time during which the tumor could not be detected. Lapatinib ditosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Timeline
- Start
- 2016-11-07
- Primary completion
- 2021-10-19
- Completion
- 2024-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lapatinib | Small molecule | — | Oral |